Filed: 8/13/2026ACC: 0001012975-26-000759
📋 What this filing means
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC filed this quarterly 13F‑HR report disclosing 13 equity positions with a total reported market value of $307.79M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
13
Positions
$307.79M
Total AUM (reported)
12.65M
Total Shares
Allocation by class
COM$219.25M71.2%
COM SHS$57.44M18.7%
ORDINARY SHARES$20.89M6.8%
COM NEW$8.02M2.6%
CL A$2.19M0.7%
Portfolio Concentration
Top 3$148.54M48.3%
4–10$144.23M46.9%
11–25$15.02M4.9%
Top 3 weight
48.3%
Top 10 weight
95.1%
Voting Authority Distribution
Total shares with voting rights: 12.65M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
12.65M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other13
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings13
Rows:
VAXCYTE INC
DFNDShares1.43M
TypeSH
Market value$82.86M
26.92%
Sole
0.00
Shared
1.43M
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
DFNDShares1.27M
TypeSH
Market value$33.18M
10.78%
Sole
0.00
Shared
1.27M
None
0.00
TREVI THERAPEUTICS INC
DFNDShares1.74M
TypeSH
Market value$32.50M
10.56%
Sole
0.00
Shared
1.74M
None
0.00
AVALYN PHARMACEUTICALS INC
DFNDShares966.79K
TypeSH
Market value$31.83M
10.34%
Sole
0.00
Shared
966.79K
None
0.00
EVOMMUNE INC
DFNDShares1.93M
TypeSH
Market value$25.61M
8.32%
Sole
0.00
Shared
1.93M
None
0.00
MAPLIGHT THERAPEUTICS INC
DFNDShares611.45K
TypeSH
Market value$21.91M
7.12%
Sole
0.00
Shared
611.45K
None
0.00
OCULIS HOLDING AG
DFNDShares1.51M
TypeSH
Market value$20.89M
6.79%
Sole
0.00
Shared
1.51M
None
0.00
BIOAGE LABS INC
DFNDShares653.37K
TypeSH
Market value$16.01M
5.20%
Sole
0.00
Shared
653.37K
None
0.00
IMMUNOME INC
DFNDShares732.51K
TypeSH
Market value$15.52M
5.04%
Sole
0.00
Shared
732.51K
None
0.00
ZENAS BIOPHARMA INC
DFNDShares490.77K
TypeSH
Market value$12.46M
4.05%
Sole
0.00
Shared
490.77K
None
0.00
AVALO THERAPEUTICS INC
DFNDShares434.03K
TypeSH
Market value$8.02M
2.61%
Sole
0.00
Shared
434.03K
None
0.00
RALLYBIO CORP
DFNDShares300.58K
TypeSH
Market value$4.81M
1.56%
Sole
0.00
Shared
300.58K
None
0.00
RECURSION PHARMACEUTICALS IN
DFNDShares595.52K
TypeSH
Market value$2.19M
0.71%
Sole
0.00
Shared
595.52K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VAXCYTE INCDFND | COM | 1.43M | SH | $82.86M 26.92% | 0.00 | 1.43M | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCDFND | COM | 1.27M | SH | $33.18M 10.78% | 0.00 | 1.27M | 0.00 |
TREVI THERAPEUTICS INCDFND | COM | 1.74M | SH | $32.50M 10.56% | 0.00 | 1.74M | 0.00 |
AVALYN PHARMACEUTICALS INCDFND | COM SHS | 966.79K | SH | $31.83M 10.34% | 0.00 | 966.79K | 0.00 |
EVOMMUNE INCDFND | COM SHS | 1.93M | SH | $25.61M 8.32% | 0.00 | 1.93M | 0.00 |
MAPLIGHT THERAPEUTICS INCDFND | COM | 611.45K | SH | $21.91M 7.12% | 0.00 | 611.45K | 0.00 |
OCULIS HOLDING AGDFND | ORDINARY SHARES | 1.51M | SH | $20.89M 6.79% | 0.00 | 1.51M | 0.00 |
BIOAGE LABS INCDFND | COM | 653.37K | SH | $16.01M 5.20% | 0.00 | 653.37K | 0.00 |
IMMUNOME INCDFND | COM | 732.51K | SH | $15.52M 5.04% | 0.00 | 732.51K | 0.00 |
ZENAS BIOPHARMA INCDFND | COM | 490.77K | SH | $12.46M 4.05% | 0.00 | 490.77K | 0.00 |
AVALO THERAPEUTICS INCDFND | COM NEW | 434.03K | SH | $8.02M 2.61% | 0.00 | 434.03K | 0.00 |
RALLYBIO CORPDFND | COM | 300.58K | SH | $4.81M 1.56% | 0.00 | 300.58K | 0.00 |
RECURSION PHARMACEUTICALS INDFND | CL A | 595.52K | SH | $2.19M 0.71% | 0.00 | 595.52K | 0.00 |